AMGN Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $265.64 = $2656.4
AMGN Charts
AMGN Prices
View the AMGN historical prices.
52WL $211.71
The 52 Week Low is $211.71 set on Thu, Jun 1, 2023.
52WH $329.72
The 52 Week High is $329.72 set on Thu, Feb 1, 2024. The current price, $265.64, is 0% below the 52 Week High.
ATH $324.82
The All-Time High is $324.82 set on Thu, Feb 1, 2024. The current price, $265.64, is 0% below the All Time High.
52 Week Range
AMGN Stock Splits
Below is the most recent stock split information. View AMGN stock split history.
Mon, Nov 22, 1999
Stock Split Ex Date
2 for 1
Adjustment Factor
AMGN Dividends
Below is the most recent dividend information. View complete AMGN dividend history of 52 dividend payments to shareholders.
3.47%
Annual Dividend Yield
$2.25 USD
Quarterly Dividend Rate
Wed, Mar 6, 2024
Declaration Date
Thu, May 16, 2024
Ex-Dividend Date
Fri, May 17, 2024
Record Date
Fri, Jun 7, 2024
Payment Date
Quarterly
Dividend Frequency
52
Dividend History
AMGN Profile
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
